ACHILLES THERAPEUTICS PLC

Dissolved Birmingham
0 employees website.com
Life sciences and medical technology
A

ACHILLES THERAPEUTICS PLC

Founded 18 Nov 2020 Dissolved Birmingham, United Kingdom 0 employees website.com
Life sciences and medical technology

Previous Company Names

ACHILLES THERAPEUTICS LIMITED 10 Feb 2021 — 10 Feb 2021
ACHILLES TX LIMITED 18 Nov 2020 — 10 Feb 2021
Accounts Due 30 Jun 2025 12 months overdue
Confirmation
Net assets £112M £51M 2023 year on year
Total assets £127M £56M 2023 year on year
Total Liabilities £15M £4M 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

C/O Teneo Financial Advisory Limited The Colmore Building 20 Colmore Circus Queensway Birmingham B4 6AT

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for ACHILLES THERAPEUTICS PLC (13027460), a dissolved life sciences and medical technology company based in Birmingham, United Kingdom. Incorporated 18 Nov 2020. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type group
Next accounts 31 Dec 2024
Due by 30 Jun 2025 12 months overdue

Balance Sheet & P&L (2019–2023)

Cash in Bank

£103.29M

Decreased by £40.35M (-28%)

Net Assets

£111.79M

Decreased by £51.49M (-32%)

Total Liabilities

£14.99M

Decreased by £4.33M (-22%)

Turnover

£4.77M

Decreased by £1.29M (-21%)

Employees

N/A

Debt Ratio

12%

Increased by 1 (+9%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

53 Allotments 135,343,444 Shares £149.32m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
10 Mar 2025158,908£131k£0.825
10 Mar 20259,253£8k£0.898
10 Mar 20257,297£7k£0.916
10 Mar 202512,977£12k£0.926
10 Mar 202513,069£12k£0.936

Officers

Officers

1 active 2 resigned
Status
Coutts, Robert WilliamDirectorBritishEngland4220 Mar 2025Active

Shareholders

Shareholders (8)

Syncona Portfolio Limited
27.0%
Baker Bros. Advisors, Lp
8.3%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 2 Ceased

Iraj Leo Kiryakos Keverian Ali

Ceased 11 Dec 2020

Ceased

Syncona Limited

Ceased 6 Apr 2021

Ceased

Group Structure

Group Structure

ACHILLES THERAPEUTICS PLC Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 May 2026InsolvencyLiquidation Voluntary Statement Of Receipts And Payments With Brought Down Date
7 Apr 2025InsolvencyLiquidation Voluntary Declaration Of Solvency
2 Apr 2025CapitalCapital Cancellation Shares By Plc
28 Mar 2025OfficersAppointment of Daniel Carey Cazel Hood as director on 20 Mar 2025
27 Mar 2025ResolutionResolutions
22 May 2026 Insolvency

Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date

7 Apr 2025 Insolvency

Liquidation Voluntary Declaration Of Solvency

2 Apr 2025 Capital

Capital Cancellation Shares By Plc

28 Mar 2025 Officers

Appointment of Daniel Carey Cazel Hood as director on 20 Mar 2025

27 Mar 2025 Resolution

Resolutions

Recent Activity

Latest Activity

Liquidation Voluntary Statement Of Receipts And Payments With Brought Down Date

2 weeks ago on 22 May 2026

Liquidation Voluntary Declaration Of Solvency

1 years ago on 7 Apr 2025

Capital Cancellation Shares By Plc

1 years ago on 2 Apr 2025

Appointment of Daniel Carey Cazel Hood as director on 20 Mar 2025

1 years ago on 28 Mar 2025

Resolutions

1 years ago on 27 Mar 2025